Sign Out
During pregnancy and postnatal periods, Hema-Plus should be administered only in cases of need and as long as the potential benefit justifies the potential risk for the fetus. No evidence has been found that Epoetin alfa can affect either the fetus, when administered during pregnancy, or the woman's fertility.
Laboratory evaluation: The hematocrit should be determined every week until the patient achieved the target value and the maintenance dosage has been established. After that a regular assessment most be instituted.
Continue with Google